Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
- 1
Lucrative Positions in the Advancing Position Market of 2024 - 2Flourishing as a Charitable Pioneer: Individual Encounters in Generosity
- 3You finally got a doctor's appointment. Here's how to get the most out of it
- 4Lula’s former human rights minister formally accused of sexual misconduct
- 5A Texas GOP congressman is retiring. Trump just endorsed his identical twin to replace him.
- Giude to Best Web based Learning Stage
- First Greenland, now Iceland? Annexation joke by Trump ally gets frosty response in the Arctic nation.
- Explainer-What Novo Nordisk's weight-loss pill approval means for company, patients
- New Gaza militia declares war on Hamas: 'Your dirty shoes are more honorable'
- Rediscovering Imagination in Adulthood: Individual Creative Excursions
- Famous SUVs With Low Energy Utilization In 2024
- 6 Asian Urban areas to Visit
- Figure out how to Amplify Your Open Record Reward
- Data centers in space: Will 2027 really be the year AI goes to orbit?
